\begin{tblr}{
    row{1} = {m},
    column{1} = {l},
    column{2,3,4,5,6,7} = {c},
    hline{1,36} = {-}{0.08em},
    hline{2} = {-}{0.05em},
}
{Herpesvirus\\(Antigen)} & Comparison ($vs.$ MS) & Direction & {AUC (95\% CI)} & {Cutoff in U/ml\\(p-value)} & Se & Sp \\
CMV & ME/CFS\_S0 & $\text{controls} < \text{cases}$ & 0.551 (0.421; 0.680) & 2.845 (0.0214) & 0.952 & 0.325 \\
    & ME/CFS\_S1 & $\text{controls} > \text{cases}$ & 0.547 (0.418; 0.677) & 29.21 (0.0701) & 0.791 & 0.425 \\
    & ME/CFS\_S2 & $\text{controls} < \text{cases}$ & 0.507 (0.389; 0.624) & 194.91 (0.0256) & 0.000 & 0.900 \\
    & ME/CFS\_S3 & $\text{controls} > \text{cases}$ & 0.545 (0.413; 0.678) & 58.755 (0.0028) & 0.938 & 0.375 \\
 &  &  &  &  &  & \\
EBV (EBNA1) & ME/CFS\_S0 & $\text{controls} > \text{cases}$ & 0.590 (0.463; 0.716) & 15.415 (0.0257) & 0.286 & 0.950 \\
    & ME/CFS\_S1 & $\text{controls} > \text{cases}$ & 0.741 (0.634; 0.848)$\ast$ & 20.035 (0.0004) & 0.465 & 0.950 \\
    & ME/CFS\_S2 & $\text{controls} > \text{cases}$ & 0.602 (0.505; 0.700)$\ast$ & 20.505 (0.0035) & 0.359 & 0.950 \\
    & ME/CFS\_S3 & $\text{controls} > \text{cases}$ & 0.621 (0.503; 0.739)$\ast$ & 19.985 (0.0028) & 0.396 & 0.950 \\
&  &  &  &  &  & \\
EBV (VCA) & ME/CFS\_S0 & $\text{controls} > \text{cases}$ & 0.668 (0.550; 0.787)$\ast$ & 132.96 (0.0257) & 0.643 & 0.675 \\
    & ME/CFS\_S1 & $\text{controls} > \text{cases}$ & 0.695 (0.580; 0.811)$\ast$ & 71.435 (0.0029) & 0.442 & 0.900 \\
    & ME/CFS\_S2 & $\text{controls} > \text{cases}$ & 0.645 (0.543; 0.746)$\ast$ & 150.345 (0.0144) & 0.707 & 0.575 \\
    & ME/CFS\_S3 & $\text{controls} > \text{cases}$ & 0.566 (0.443; 0.690) & 139.315 (0.0687) & 0.583 & 0.650 \\
&  &  &  &  &  & \\
HHV6 & ME/CFS\_S0 & $\text{controls} > \text{cases}$ & 0.590 (0.465; 0.714) & 78.105 (0.0374) & 0.881 & 0.350 \\
    & ME/CFS\_S1 & $\text{controls} > \text{cases}$ & 0.558 (0.429; 0.687) & 103.94 (0.0057) & 1.000 & 0.225 \\
    & ME/CFS\_S2 & $\text{controls} > \text{cases}$ & 0.518 (0.403; 0.632) & 130.625 (0.0256) & 0.978 & 0.150 \\
    & ME/CFS\_S3 & $\text{controls} > \text{cases}$ & 0.520 (0.391; 0.649) & 91.82 (0.0271) & 0.938 & 0.275 \\
&  &  &  &  &  & \\
HSV1 & ME/CFS\_S0 & $\text{controls} > \text{cases}$ & 0.579 (0.454; 0.704) & 2.14 (0.0371) & 0.167 & 1.000 \\
    & ME/CFS\_S1 & $\text{controls} > \text{cases}$ & 0.635 (0.513; 0.756)$\ast$ & 2.84 (0.0104) & 0.256 & 0.975 \\
    & ME/CFS\_S2 & $\text{controls} > \text{cases}$ & 0.596 (0.497; 0.696) & 2.755 (0.0303) & 0.196 & 0.975 \\
    & ME/CFS\_S3 & $\text{controls} > \text{cases}$ & 0.550 (0.429; 0.671) & 2.8 (0.0182) & 0.250 & 0.975 \\
&  &  &  &  &  & \\
HSV2 & ME/CFS\_S0 & $\text{controls} < \text{cases}$ & 0.557 (0.432; 0.683) & 231.395 (0.0737) & 0.119 & 1.000 \\
    & ME/CFS\_S1 & $\text{controls} > \text{cases}$ & 0.536 (0.409; 0.663) & 6.81 (0.1600) & 0.628 & 0.55 \\
    & ME/CFS\_S2 & $\text{controls} > \text{cases}$ & 0.520 (0.410; 0.629) & 7.03 (0.1343) & 0.609 & 0.550 \\
    & ME/CFS\_S3 & $\text{controls} > \text{cases}$ & 0.527 (0.402; 0.651) & 2.895 (0.1341) & 0.771 & 0.400 \\
&  &  &  &  &  & \\
VZV & ME/CFS\_S0 & $\text{controls} > \text{cases}$ & 0.596 (0.472; 0.721) & 141.005 (0.0737) & 0.571 & 0.650 \\
    & ME/CFS\_S1 & $\text{controls} > \text{cases}$ & 0.667 (0.548; 0.786)$\ast$ & 139.495 (0.0025) & 0.744 & 0.650 \\
    & ME/CFS\_S2 & $\text{controls} > \text{cases}$ & 0.532 (0.418; 0.646) & 148.24 (0.5054) & 0.554 & 0.550 \\
    & ME/CFS\_S3 & $\text{controls} > \text{cases}$ & 0.546 (0.421; 0.672) & 180.995 (0.0981) & 0.792 & 0.400
 \end{tblr}